136133-18-1Relevant academic research and scientific papers
AZOLOPYRIMIDINE FOR THE TREATMENT OF CANCER-RELATED DISORDERS
-
Paragraph 0308, (2018/08/12)
Compound that is an inhibitor of at least one of the A2A and A2B adenosine receptors, and compositions containing the compound and methods for synthesizing the compound, are described herein. The use of such compound and compositions for the treatment of a diverse array of diseases, disorders, and conditions, including cancer- and immune-related disorders that are mediated, at least in part, by the adenosine A2A receptor and/or the adenosine A2B receptor.
Platinum(ii) complexes with bidentate NN and tridentate NNO ligands for C-H bond activation
Duin, Marcel A.,Ernsting, Jan M.,Elsevier, Cornelis J.
, p. 764 - 784 (2008/12/22)
A series of neutral and cationic methylplatinum(II) complexes with bidentate NN and tridentate NNO ligands has been prepared. The complexes involving tridentate NNO ligands were expected to be easier to handle than those with NN ligands, which has indeed
Synthesis of novel chiral lipophilic pyridyl-containing β-amino alcohol ligands and enantioselective hydrolysis of α-amino acid esters by chiral metallomicelles
You, Jingsong,Yu, Xiaoqi,Liu, Ke,Tao, Lin,Xiang, Qingxiang,Xie, Rugang
, p. 243 - 254 (2007/10/03)
Seven novel chiral lipophilic pyridyl-containing β-amino alcohol ligands have been synthesized by coupling of 6-alkoxymethyl-2- chloromethylpyridine 3 with the corresponding chiral β-amino alcohols or L- cysteine. Their metal ion complexes have been inves
